|
|
||||||||
The Journal of Immunology, Vol 144, Issue 11 4262-4268, Copyright © 1990 by American Association of Immunologists
ARTICLES |
MW Nickells and JP Atkinson
Howard Hughes Medical Institute Laboratories, Washington University School of Medicine, St. Louis, MO 63110.
We have identified and characterized C3b binding proteins of two primates, orangutan (Pongo pygmaeus) and gorilla (Gorilla gorilla). Detergent solubilized 125I surface-labeled E and PBMC were subjected to affinity chromatography with homologous or human iC3/C3b. These ligands bound a 225,000 single chain protein from orangutan E and PBMC and a 220,000 protein from gorilla E. Proteins of the same Mr were immunoprecipitated by a rabbit polyclonal and two murine mAb to the human CR1 (CD35). The C3b binding protein of gorilla E aligned with that of the common human CR1 polymorphic size variant. Human or orangutan iC3 was also a ligand for a surface-labeled protein doublet of 59,000 and 65,000 from orangutan E. The doublet pattern and mol wts are similar to membrane cofactor protein (or CD46). Further, this doublet was immunoprecipitated by a mAb to human MCP. The MCP-like protein doublet was not isolated from gorilla or human E. Decay accelerating factor (DAF) of orangutan E was also identified and was structurally and antigenically distinct from the MCP-like protein. Orangutan or gorilla E preparations were a cofactor for the cleavage of human iC3 by human factor I and produced the same cleavage fragments as human CR1. Cofactor activity of orangutan E was partially inhibited by preclearance of CR1 and more completely inhibited by preclearance of MCP. Cofactor activity of gorilla E was inhibited by coincubation with a monoclonal antibody to human CR1. These data indicate that the orangutan and gorilla high m.w. proteins are equivalent to human CR1. The orangutan E membrane protein doublet with m.w. of 59,000 and 65,000 possesses biochemical, antigenic, and functional properties of human membrane cofactor protein.
This article has been cited by other articles:
![]() |
M. K. Liszewski, M. K. Leung, R. Hauhart, R. M. L. Buller, P. Bertram, X. Wang, A. M. Rosengard, G. J. Kotwal, and J. P. Atkinson Structure and Regulatory Profile of the Monkeypox Inhibitor of Complement: Comparison to Homologs in Vaccinia and Variola and Evidence for Dimer Formation J. Immunol., March 15, 2006; 176(6): 3725 - 3734. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Gustafsson, A. Segerman, K. Lindman, Y.-F. Mei, and G. Wadell The Arg279Glu Substitution in the Adenovirus Type 11p (Ad11p) Fiber Knob Abolishes EDTA-Resistant Binding to A549 and CHO-CD46 Cells, Converting the Phenotype to That of Ad7p J. Virol., February 15, 2006; 80(4): 1897 - 1905. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Perez de la Lastra, C. L. Harris, S. J. Hinchliffe, D. S. Holt, N. K. Rushmere, and B. P. Morgan Pigs Express Multiple Forms of Decay-Accelerating Factor (CD55), All of Which Contain Only Three Short Consensus Repeats J. Immunol., September 1, 2000; 165(5): 2563 - 2573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krych-Goldberg, R. E. Hauhart, V. B. Subramanian, B. M. Yurcisin II, D. L. Crimmins, D. E. Hourcade, and J. P. Atkinson Decay Accelerating Activity of Complement Receptor Type 1 (CD35). TWO ACTIVE SITES ARE REQUIRED FOR DISSOCIATING C5 CONVERTASES J. Biol. Chem., October 29, 1999; 274(44): 31160 - 31168. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Hinchliffe, O. B. Spiller, N. K. Rushmere, and B. P. Morgan Molecular Cloning and Functional Characterization of the Rat Analogue of Human Decay-Accelerating Factor (CD55) J. Immunol., November 15, 1998; 161(10): 5695 - 5703. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Iwata, T. Seya, Y. Yanagi, J. M. Pesando, P. M. Johnson, M. Okabe, S. Ueda, H. Ariga, and S. Nagasawa Diversity of Sites for Measles Virus Binding and for Inactivation of Complement C3b and C4b on Membrane Cofactor Protein CD46 J. Biol. Chem., June 23, 1995; 270(25): 15148 - 15152. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Liszewski, M. Leung, W. Cui, V. B. Subramanian, J. Parkinson, P. N. Barlow, M. Manchester, and J. P. Atkinson Dissecting Sites Important for Complement Regulatory Activity in Membrane Cofactor Protein (MCP; CD46) J. Biol. Chem., November 22, 2000; 275(48): 37692 - 37701. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |